Original Research
Accepted on 29 Dec 2025
Partially Hydrolyzed Formula with High sn-2 Palmitic Acid on Eosinophils and Outcomes in Preterm Infants: PRIOR Secondary Analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
Type at least 3 characters
1,831 articles
articles
Review
Accepted on 29 Dec 2025
Glutathione and Neurodegenerative Diseases: Immunopharmacological Implications
in Inflammation Pharmacology
Frontiers in Pharmacology
Original Research
Accepted on 25 Dec 2025
Multi-omics Integration and Machine Learning-Driven Construction of an Immunogenic Cell Death Prognostic Model for Colon Cancer and Functional Validation of FCGR2A
in Inflammation Pharmacology
Frontiers in Pharmacology
Review
Accepted on 24 Dec 2025
MOLECULAR AND PATHOPHYSIOLOGICAL INTERSECTIONS BETWEEN ARTERIAL HYPERTENSION, PULMONARY INFLAMMATION AND DIABETES MELLITUS
in Inflammation Pharmacology
Frontiers in Pharmacology
Original Research
Accepted on 22 Dec 2025
Characterization and Anti-inflammatory Studies Based on Supramolecular Assemblies Formed by Chlorogenic Acids and Metal Ions
in Inflammation Pharmacology
Frontiers in Pharmacology
Original Research
Published on 19 Dec 2025
Oleanolic acid cubic liquid crystal nanoparticle-based thermosensitive gel attenuates knee osteoarthritis symptoms in rats
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1730566
- 534 views
Original Research
Published on 18 Dec 2025
Inflammatory response in CF airway epithelial cells: a comparative study of modulators and wild-type CFTR rescue
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1657688
- 402 views
Systematic Review
Accepted on 17 Dec 2025
Knowledge Domain and Evolutionary Trends of P2Y Receptors in Cardiovascular Diseases: A Bibliometric and Altmetric Analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
- 121 views
General Commentary
Accepted on 15 Dec 2025
Commentary: CU06-1004 inhibits the progression of chronic colitis and colitis-associated colorectal cancer by suppressing inflammation
in Inflammation Pharmacology
Frontiers in Pharmacology
- 120 views
Review
Accepted on 12 Dec 2025
κ-Opioid Receptor:From Analgesic Target to Neuroimmune Hub
in Inflammation Pharmacology
Frontiers in Pharmacology
- 174 views
Review
Accepted on 11 Dec 2025
Advances in pulmonary neuroendocrine cells and their cellular interactions in asthma pathogenesis
in Inflammation Pharmacology
Frontiers in Pharmacology
- 126 views
Original Research
Published on 10 Dec 2025
Isoliensinine confers neuroprotection and alleviates LPS-induced neuroinflammation in microglia by regulating the MAPK/NF-κB signaling
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1675865
- 619 views
Review
Published on 10 Dec 2025
Immune modulation in inflammatory bowel disease: therapeutic promise of baicalein
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1723606
- 595 views
Review
Accepted on 09 Dec 2025
Molecular insights into NLRP3 inflammasome and miRNA modulation in oral cancer
in Inflammation Pharmacology
Frontiers in Pharmacology
- 241 views
Review
Accepted on 08 Dec 2025
Cycloastragenol in Inflammation-Related Diseases: Mechanisms, Pharmacokinetics, and Translational Prospects
in Inflammation Pharmacology
Frontiers in Pharmacology
- 138 views
Systematic Review
Published on 04 Dec 2025
Effectiveness and safety of tocilizumab in refractory noninfectious uveitis: a systematic review and meta-analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1694311
- 774 views
Mini Review
Published on 04 Dec 2025
CX3CR1: a potential microglia-specific PET imaging target in Alzheimer’s and Parkinson’s diseases
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1678159
- 839 views
Review
Published on 03 Dec 2025
Dapansutrile in multidisciplinary therapeutic applications: mechanisms and clinical perspectives
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1731165
- 880 views
Original Research
Published on 03 Dec 2025
The clinical value of PLR, NLR, and MLR in predicting mortality risk in hospitalized patients
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1736947
- 742 views
Original Research
Accepted on 02 Dec 2025
Neoantigen immune responses in healthy volunteers: insights from multiple integrated keyhole limpet hemocyanin challenge studies on repeated immunization and response covariates
in Inflammation Pharmacology
Frontiers in Pharmacology
- 153 views
Opinion
Published on 02 Dec 2025
CCR5-targeted γδ CAR-T cells: a rational step toward HIV-resistant allogeneic immunotherapy
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1734423
- 628 views
Original Research
Published on 01 Dec 2025
Acetyl-11-keto-beta-boswellic acid ameliorates monosodium iodoacetate-induced osteoarthritis in rats: implications of HMGB1/TLR4/NF-κB and Nrf2/HO-1
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1694803
- 993 views
Review
Accepted on 30 Nov 2025
Flavonoids in inflammatory bowel disease: Multi-dimensional mechanisms via modulation of the intestinal barrier-microbiota-immune axis
in Inflammation Pharmacology
Frontiers in Pharmacology
- 123 views
Original Research
Published on 28 Nov 2025
Omega 3 fatty acid docosahexaenoic acid (DHA) mitigates inflammatory responses in experimental sepsis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1708348
- 1,183 views